Foley Represents Nestle Skin Care and Galderma Against Truinject in Successful Institution of Two Inter Partes Reviews of Patents for Injection Training System
17 November 2020
Foley & Lardner is representing Galderma S.A. and Nestle Skin Health, Inc. in two IPR’s at the PTAB, challenging Truinject Corp.’s patents on automated detection of performance characteristics in an injection training system (U.S. Patent Nos. 10,290,231 and 10,290,232) following a district court complaint filed by Truinject based on the patents. On November 17, 2020, the PTAB granted institution of both IPRs, IPR2020-00935 and -00937 on all challenged claims on the requested grounds. Galderma S.A., formerly a subsidiary of Nestlé, is a global pharmaceutical company specializing in dermatological treatments and skin care products. The Foley team includes George Beck, Stephen B. Maebius, Chase Brill, and Kiri Lee Sharon.
People
Related News
22 April 2024
Press Releases
Foley Adds IP Partners Ngai Zhang and Drew Schulte, Enhancing Innovative Technology Capabilities
Foley & Lardner LLP announced today that it has bolstered its Innovative Technology Sector and Electronics Practice with the addition of partners Ngai Zhang and Drew Schulte in Washington, D.C. and Miami, respectively.
15 April 2024
Press Releases
Foley Names Andrew Wronski as Manufacturing Sector Chair
Foley & Lardner LLP is pleased to announce that Andrew “Andy” Wronski has been named chair of the firm’s Manufacturing Sector, effective April 15, 2024.
03 April 2024
Press Releases
Foley Continues East Coast Growth with Transactions Partner Joe Bernardi, Strengthening Capabilities in the Technology Sector
Foley & Lardner LLP announced today that the firm has bolstered its Innovative Technology Sector and Private Equity and M&A Practices with the addition of partner Joe Bernardi in Boston.